Skip to content

Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (LRFN3)

Homo sapiens — UniProt Q9BTN0

Gene: LRFN3Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (LRFN3) is a protein from Homo sapiens identified by UniProt accession Q9BTN0, 628 residues long. MolForge cross-references it against 0 known binders and 34 disease associations.

  • UniProt accession: Q9BTN0; gene symbol LRFN3.
  • Organism: Homo sapiens.
  • Length: 628 amino acids.
  • Top disease associations (Open Targets): thyroid gland adenocarcinoma, lung adenocarcinoma and calcium measurement.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameLeucine-rich repeat and fibronectin type-III domain-containing protein 3
UniProt accessionQ9BTN0
GeneLRFN3
OrganismHomo sapiens
Length628 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (34)

Diseases linked to this target (Open Targets).

  • thyroid gland adenocarcinoma · score 0.18
  • lung adenocarcinoma · score 0.18
  • calcium measurement · score 0.11
  • isolated congenital hypogonadotropic hypogonadism · score 0.06
  • 46,XX testicular disorder of sex development · score 0.06
  • azoospermia · score 0.06
  • 46,XY complete gonadal dysgenesis · score 0.06
  • 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency · score 0.05
  • familial male-limited precocious puberty · score 0.05
  • Testicular regression syndrome · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-Q9BTN0-F1alphafoldPREDICTED77.42—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for Q9BTN0.

Amino-acid sequence (628 residues)

MAILPLLLCL LPLAPASSPP QSATPSPCPR RCRCQTQSLP LSVLCPGAGL LFVPPSLDRR AAELRLADNF IASVRRRDLA NMTGLLHLSL SRNTIRHVAA GAFADLRALR ALHLDGNRLT SLGEGQLRGL VNLRHLILSN NQLAALAAGA LDDCAETLED LDLSYNNLEQ LPWEALGRLG NVNTLGLDHN LLASVPAGAF SRLHKLARLD MTSNRLTTIP PDPLFSRLPL LARPRGSPAS ALVLAFGGNP LHCNCELVWL RRLAREDDLE ACASPPALGG RYFWAVGEEE FVCEPPVVTH RSPPLAVPAG RPAALRCRAV GDPEPRVRWV SPQGRLLGNS SRARAFPNGT LELLVTEPGD GGIFTCIAAN AAGEATAAVE LTVGPPPPPQ LANSTSCDPP RDGDPDALTP PSAASASAKV ADTGPPTDRG VQVTEHGATA ALVQWPDQRP IPGIRMYQIQ YNSSADDILV YRMIPAESRS FLLTDLASGR TYDLCVLAVY EDSATGLTAT RPVGCARFST EPALRPCGAP HAPFLGGTMI IALGGVIVAS VLVFIFVLLM RYKVHGGQPP GKAKIPAPVS SVCSQTNGAL GPTPTPAPPA PEPAALRAHT VVQLDCEPWG PGHEPVGP

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with LRFN3?

The strongest Open Targets associations for LRFN3 are thyroid gland adenocarcinoma, lung adenocarcinoma, calcium measurement, isolated congenital hypogonadotropic hypogonadism and 46,XX testicular disorder of sex development.

How long is the LRFN3 protein?

The Homo sapiens LRFN3 protein (UniProt Q9BTN0) is 628 amino acids long.

Browse: Targets: L · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Leucine-rich repeat and fibronectin type-III domain-containing protein 3 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtQ9BTN0
GeneLRFN3
OrganismHomo sapiens
Length628
Binders0
Diseases34
View on UniProt